262 related articles for article (PubMed ID: 17943782)
41. Traditional suburethral sling operations for urinary incontinence in women.
Saraswat L; Rehman H; Omar MI; Cody JD; Aluko P; Glazener CM
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD001754. PubMed ID: 31990055
[TBL] [Abstract][Full Text] [Related]
42. [Clinical effectiveness and safety of combined therapy with alpha-blocker and an anticholinergic drug for bladder outlet obstruction with overactive bladder: a Meta-analysis of outcomes].
Liu B; Li J; Wang Y; Wu Y
Zhonghua Wai Ke Za Zhi; 2014 May; 52(5):376-80. PubMed ID: 25034747
[TBL] [Abstract][Full Text] [Related]
43. OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder.
Sievert KD; Chapple C; Herschorn S; Joshi M; Zhou J; Nardo C; Nitti VW
Int J Clin Pract; 2014 Oct; 68(10):1246-56. PubMed ID: 24754838
[TBL] [Abstract][Full Text] [Related]
44. Tricyclic and related drugs for nocturnal enuresis in children.
Caldwell PH; Sureshkumar P; Wong WC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD002117. PubMed ID: 26789925
[TBL] [Abstract][Full Text] [Related]
45. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials.
Bapir R; Bhatti KH; Eliwa A; García-Perdomo HA; Gherabi N; Hennessey D; Magri V; Mourmouris P; Ouattara A; Perletti G; Philipraj J; Stamatiou K; Trinchieri A; Buchholz N
Arch Ital Urol Androl; 2022 Dec; 94(4):492-506. PubMed ID: 36576454
[TBL] [Abstract][Full Text] [Related]
47. Single-incision sling operations for urinary incontinence in women.
Nambiar A; Cody JD; Jeffery ST
Cochrane Database Syst Rev; 2014 Jun; (6):CD008709. PubMed ID: 24880654
[TBL] [Abstract][Full Text] [Related]
48. [Comprehensive pharmacologic management of overactive bladder].
Krivoborodov GG; Tur EI
Urologiia; 2017 Apr; (1):82-88. PubMed ID: 28394529
[TBL] [Abstract][Full Text] [Related]
49. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Utomo E; Groen J; Blok BF
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004927. PubMed ID: 24859260
[TBL] [Abstract][Full Text] [Related]
50. Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis.
Sweeney P; Mutambirwa S; Van An N; Sharma JB; Vanamail P
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3703-12. PubMed ID: 27649675
[TBL] [Abstract][Full Text] [Related]
51. Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study.
Chancellor MB; Yehoshua A; Waweru C; Globe D; Cheng IN; Campbell KL; Joshi M; Pulicharam R
Int Urol Nephrol; 2016 Jul; 48(7):1029-36. PubMed ID: 27032397
[TBL] [Abstract][Full Text] [Related]
52. Electrical stimulation with non-implanted devices for stress urinary incontinence in women.
Stewart F; Berghmans B; Bø K; Glazener CM
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012390. PubMed ID: 29271482
[TBL] [Abstract][Full Text] [Related]
53. Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020.
Carr DN; Macharia A; Hacker MR; Winkelman WD
Am J Obstet Gynecol; 2023 Sep; 229(3):316.e1-316.e7. PubMed ID: 37244459
[TBL] [Abstract][Full Text] [Related]
54. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women.
Dumoulin C; Cacciari LP; Hay-Smith EJC
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD005654. PubMed ID: 30288727
[TBL] [Abstract][Full Text] [Related]
55. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
56. [Efficacy and safety of available therapies in the management of idiopathic overactive bladder: A systematic review of the literature].
Moyson J; Legrand F; Vanden Bossche M; Quackels T; Roumeguère T
Prog Urol; 2017 Mar; 27(4):203-228. PubMed ID: 28228331
[TBL] [Abstract][Full Text] [Related]
57. Intravesical treatments for painful bladder syndrome/ interstitial cystitis.
Dawson TE; Jamison J
Cochrane Database Syst Rev; 2007 Oct; (4):CD006113. PubMed ID: 17943887
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological interventions for somatoform disorders in adults.
Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
[TBL] [Abstract][Full Text] [Related]
59. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
[TBL] [Abstract][Full Text] [Related]
60. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
